Related Experiment Videos
[The cardioprotective effect of perindopril in rats with experimental cardiosclerosis]
E I Kalenikova1, E A Gorodetskaia, N V Zakharova
1Laboratory of Experimental Pharmacology, Cardiological-Production Complex, Russian Federation Ministry of Public Health, Moscow, Russia.
Abstract:
Rats with experimental cardiosclerosis detected 21 days after embolization of the coronary arteries were subjected to early chronic perindopril administration (per os, 2 mg/kg once a day on days 2-20 after immobilization. As a result, the number of scars reduced, focal cardiosclerosis, dystrophy and hypertrophy of the cardiomyocytes were less pronounced, and the content of cellular glycogen increased. The cardioprotective effect was attended with a normalizing influence on the renin-angiotensin system parameters which were significantly changed after experimental damage to the myocardium: perindopril restored angiotensin I clearance and the level of angiotensin II production in the lungs.